Intestinal NF-κB is activated, mainly as p50 homodimers, by platelet-activating factor

Biochimica et Biophysica Acta - Lipids and Lipid Metabolism

Volumn 1392, Issue 2-3, 1998, Pages 185-192

  De Plaen, Isabelle G ^a   Tan, Xiao Di ^a   Chang, Hong ^a   Qu, Xiao Wu ^a   Liu, Qian Ping ^a   Hsueh, Wei ^a  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Nuclear factor B; Platelet activating factor; Small intestine

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; THROMBOCYTE ACTIVATING FACTOR; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR DISTRIBUTION; DNA BINDING; GENE TRANSLOCATION; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; ANIMAL; CELL NUCLEUS; CHEMISTRY; DIMERIZATION; EPITHELIUM CELL; ILEUM; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE;

ANIMALS; BIOLOGICAL TRANSPORT; CELL NUCLEUS; DIMERIZATION; DNA; EPITHELIAL CELLS; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE, SMALL; MALE; NEUTROPHILS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PLATELET ACTIVATING FACTOR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032525398     PISSN: 00052760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2760(98)00024-1     Document Type: Article

References (36)

1. Snyder F. Platelet activating factor and related acetylated lipids as potent biologically active cellular mediators. Am. J. Physiol. 259:1990;C697-708.
2. Gonzalez-Crussi F., Hsueh W. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin. Am. J. Pathol. 112:1983;127-135.
3. Hsueh W., Gonzalez-Crussi F., Arroyave J.L. Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J. 1:1987;403-405.
4. Sun X.M., Hsueh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor. J. Clin. Invest. 81:1988;1328-1331.
5. Kubes P., Ibbotson G., Russell J., Wallace J.L., Granger D.N. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence. Am. J. Physiol. 259:1990;G300-305.
6. Caplan M.S., Sun X.M., Hsueh W., Hageman J.R. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J. Pediatr. 116:1990;960-964.
7. Stenson W.F. Platelet-activating factor and inflammatory bowel disease. Gastroenterology. 95:(5):1988;1416-1419.
8. Denizot Y., Chaussade S., Benveniste J., Couturier D. Presence of PAF-acether in stool of patients with infectious diarrhoea [letter]. J. Infect. Dis. 163:(5):1991;1168.
9. Huang L., Tan X., Crawford S.E., Hsueh W. Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology. 83:1994;65-69.
10. Prescott S.M., McIntyre T.M., Zimmerman G.A. The role of platelet-activating factor in endothelial cells. Thromb. Haemost. 64:1990;99-103.
11. Zimmerman B.J., Holt J.W., Paulson J.C., Anderson D.C., Miyasaka M., Tamatani T., Todd R.F., Rusche J.R., Granger D.N. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am. J. Physiol. 266:1994;H847-H853.
12. Sun X.-M., Qu X.-W., Huang W., Granger D.N., Bree M., Hsueh W. The role of leukocyte beta 2-integrin in PAF-induced shock and intestinal injury. Am. J. Physiol. 270:1996;G184-190.
13. Kravchenko V.V., Pan Z., Han J., Herbert J.M., Ulevitch R.J., Ye R.D. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway. J. Biol. Chem. 270:1995;14928-14934.
14. Tan X., Sun X., Gonzalez-Crussi F.X., Gonzalez-Crussi F., Hsueh W. PAF and TNF increase the precursor of NF-kappa B p50 mRNA in mouse intestine: quantitative analysis by competitive PCR. Biochim. Biophys. Acta. 1215:1994;157-162.
15. Baeuerle P.A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
16. Kopp E.B., Ghosh S. NF-kappa B and rel proteins in innate immunity. Adv. Immunol. 58:1995;1-27.
17. Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-κB activation and neutrophilic lung inflammation. J. Immunol. 157:1996;1630-1637.
18. Deryckere F., Gannon F. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. Biotechniques. 16:1994;405.
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
20. Flint N., Cove F.L., Evans G.S. A low-temperature method for the isolation of small-intestinal epithelium along the crypt-villus axis. Biochem. J. 280:1991;331-334.
21. Lichtsteiner S., Wuarin J., Schibler U. The interplay of DNA-binding proteins on the promoter of the mouse albumin gene. Cell. 51:1987;963-973.
22. Hsu S.-M., Raine L., Fanger H. A comparative study of the peroxidase-antiperoxidase method and an Avidin-Biotin Complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75:1981;734-738.
23. Essani N.A., McGuire G.M., Manning A.M., Jaeschke H. Endotoxin-induced activation of the nuclear transcription factor kappa B and expression of E-selectin messenger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J. Immunol. 156:1996;2956-2963.
24. Franzoso G., Bours V., Azarenko V., Park S., Tomita-Yamaguchi M., Kanno T., Brown K., Siebenlist U. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites. EMBO J. 12:1993;3893-3901.
25. Kang S.M., Tran A.C., Grilli M., Lenardo M.J. NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science. 256:1992;1452-1456.
26. Snapper C.M., Zelazowski P., Rosas F.R., Kehry M.R., Tian M., Baltimore D., Sha W.C. B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156:1996;183-191.
27. LeClair K.P., Blanar M.A., Sharp P.A. The p50 subunit of NF-kappa B associates with the NF-IL6 transcription factor. Proc. Natl. Acad. Sci. USA. 89:1992;8145-8149.
28. Stein B., Cogswell P.C., Baldwin A.S. Jr. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction. Mol. Cell. Biol. 13:1993;3964-3974.
29. Moore P.A., Ruben S.M., Rosen C.A. Conservation of transcriptional activation functions of the NF-kappa B p50 and p65 subunits in mammalian cells and Saccharomyces cerevisiae. Mol. Cell. Biol. 13:1993;1666-1674.
30. Kretzschmar M., Meisterernst M., Scheidereit C., Li G., Roeder R.G. Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitro. Genes Dev. 6:1992;761-774.
31. Sakurai H., Hisada Y., Ueno M., Sugiura M., Kawashima K., Sugita T. Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim. Biophys. Acta. 1316:1996;132-138.
32. Narayanan R., Higgins K.A., Perez J.R., Coleman T.A., Rosen C.A. Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model. Mol. Cell. Biol. 13:1993;3802-3810.
33. Ziegler-Heitbrock H.W., Wedel A., Schraut W., Strobel M., Wendelgass P., Sternsdorf T., Bauerle P.A., Haas J.G., Riethmuller G. Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J. Biol. Chem. 269:1994;17001-17004.
34. Pan J., McEver R.P. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family. J. Biol. Chem. 270:1995;23077-23083.
35. Weyrich A.S., McIntyre T.M., McEver R.P., Prescott S.M., Zimmerman G.A. Monocyte tethering by P-selectin regulates monocyte chemotactic protein-1 and tumor necrosis factor-a secretion. J. Clin. Invest. 95:1995;2297-2303.
36. Sun X., Rozenfeld R.A., Qu X., Huang W., Gonzalez-Crussi F., Hsueh W. P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am. J. Physiol. 273:1997;G56-61.